SYRS
Syros Pharmaceuticals, Inc. · Healthcare
Director Srinivas Akkaraju bought $4.0M of Syros Pharmaceuticals, Inc.
Bought$3,999,998
$4.42Price
904,977Shares
+102%Stake
What SYRS did for a copier
Prices for SYRS after this filing aren't in yet.
Srinivas Akkaraju's record
15 other buys with 3 months of prices since 2017: on average +104.5% against the S&P 500, and 8 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Dec 21. Filed Tue, Dec 26, 12:24 PM ET, during the session. Not investment advice.